30
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Transdiagnostic Approaches to Mental Health Problems: Current Status and Future Directions

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Despite a longstanding and widespread influence of the diagnostic approach to mental ill health, there is an emerging and growing consensus that such psychiatric nosologies may no longer be fit for purpose in research and clinical practice. In their place, there is gathering support for a “transdiagnostic” approach that cuts across traditional diagnostic boundaries or, more radically, sets them aside altogether, to provide novel insights into how we might understand mental health difficulties. Removing the distinctions between proposed psychiatric taxa at the level of classification opens up new ways of classifying mental health problems, suggests alternative conceptualizations of the processes implicated in mental health, and provides a platform for novel ways of thinking about onset, maintenance, and clinical treatment and recovery from experiences of disabling mental distress. In this Introduction to a Special Section on Transdiagnostic Approaches to Psychopathology, we provide a narrative review of the transdiagnostic literature in order to situate the Special Section articles in context. We begin with a brief history of the diagnostic approach and outline several challenges it currently faces that arguably limit its applicability in current mental health science and practice. We then review several recent transdiagnostic approaches to classification, biopsychosocial processes, and clinical interventions, highlighting promising novel developments. Finally, we present some key challenges facing transdiagnostic science and make suggestions for a way forward.

          What is the public health significance of this article?

          Traditional diagnostic systems may no longer be fit for purpose for classifying mental ill health, facilitating understanding of its core underlying biopsychosocial processes, nor driving clinical developments. Here we propose that ‘transdiagnostic’ approaches have the potential to better represent the clinical and scientific reality of mental health problems, reflecting the complexity, dimensionality and comorbidity that is the norm in clinical practice.

          Related collections

          Most cited references95

          • Record: found
          • Abstract: found
          • Article: not found

          Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample.

          The comorbidity of current and lifetime DSM-IV anxiety and mood disorders was examined in 1,127 outpatients who were assessed with the Anxiety Disorders Interview Schedule for DSM-IV: Lifetime version (ADIS-IV-L). The current and lifetime prevalence of additional Axis I disorders in principal anxiety and mood disorders was found to be 57% and 81%, respectively. The principal diagnostic categories associated with the highest comorbidity rates were mood disorders, posttraumatic stress disorder (PTSD), and generalized anxiety disorder (GAD). A high rate of lifetime comorbidity was found between the anxiety and mood disorders; the lifetime association with mood disorders was particularly strong for PTSD, GAD, obsessive-compulsive disorder, and social phobia. The findings are discussed in regard to their implications for the classification of emotional disorders.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            How does mindfulness-based cognitive therapy work?

            Mindfulness-based cognitive therapy (MBCT) is an efficacious psychosocial intervention for recurrent depression (Kuyken et al., 2008; Ma & Teasdale, 2004; Teasdale et al., 2000). To date, no compelling research addresses MBCT's mechanisms of change. This study determines whether MBCT's treatment effects are mediated by enhancement of mindfulness and self-compassion across treatment, and/or by alterations in post-treatment cognitive reactivity. The study was embedded in a randomized controlled trial comparing MBCT with maintenance antidepressants (mADM) with 15-month follow-up (Kuyken et al., 2008). Mindfulness and self-compassion were assessed before and after MBCT treatment (or at equivalent time points in the mADM group). Post-treatment reactivity was assessed one month after the MBCT group sessions or at the equivalent time point in the mADM group. One hundred and twenty-three patients with ≥3 prior depressive episodes, and successfully treated with antidepressants, were randomized either to mADM or MBCT. The MBCT arm involved participation in MBCT, a group-based psychosocial intervention that teaches mindfulness skills, and discontinuation of ADM. The mADM arm involved maintenance on a therapeutic ADM dose for the duration of follow-up. Interviewer-administered outcome measures assessed depressive symptoms and relapse/recurrence across 15-month follow-up. Mindfulness and self-compassion were measured using self-report questionnaire. Cognitive reactivity was operationalized as change in depressive thinking during a laboratory mood induction. MBCT's effects were mediated by enhancement of mindfulness and self-compassion across treatment. MBCT also changed the nature of the relationship between post-treatment cognitive reactivity and outcome. Greater reactivity predicted worse outcome for mADM participants but this relationship was not evident in the MBCT group. MBCT's treatment effects are mediated by augmented self-compassion and mindfulness, along with a decoupling of the relationship between reactivity of depressive thinking and poor outcome. This decoupling is associated with the cultivation of self-compassion across treatment. Copyright © 2010 Elsevier Ltd. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Quality-of-life impairment in depressive and anxiety disorders.

              Previous reports demonstrating quality-of-life impairment in anxiety and affective disorders have relied upon epidemiological samples or relatively small clinical studies. Administration of the same quality-of-life scale, the Quality of Life Enjoyment and Satisfaction Questionnaire, to subjects entering multiple large-scale trials for depression and anxiety disorders allowed us to compare the impact of these disorders on quality of life. Baseline Quality of Life Enjoyment and Satisfaction Questionnaire, demographic, and clinical data from 11 treatment trials, including studies of major depressive disorder, chronic/double depression, dysthymic disorder, panic disorder, obsessive-compulsive disorder (OCD), social phobia, premenstrual dysphoric disorder, and posttraumatic stress disorder (PTSD) were analyzed. The proportion of patients with clinically severe impairment (two or more standard deviations below the community norm) in quality of life varied with different diagnoses: major depressive disorder (63%), chronic/double depression (85%), dysthymic disorder (56%), panic disorder (20%), OCD (26%), social phobia (21%), premenstrual dysphoric disorder (31%), and PTSD (59%). Regression analyses conducted for each disorder suggested that illness-specific symptom scales were significantly associated with baseline quality of life but explained only a small to modest proportion of the variance in Quality of Life Enjoyment and Satisfaction Questionnaire scores. Subjects with affective or anxiety disorders who enter clinical trials have significant quality-of-life impairment, although the degree of dysfunction varies. Diagnostic-specific symptom measures explained only a small proportion of the variance in quality of life, suggesting that an individual's perception of quality of life is an additional factor that should be part of a complete assessment.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                J Consult Clin Psychol
                J Consult Clin Psychol
                Journal of Consulting and Clinical Psychology
                American Psychological Association
                978-1-4338-9344-5
                0022-006X
                1939-2117
                March 2020
                : 88
                : 3 , Transdiagnostic Approaches to Mental Health
                : 179-195
                Affiliations
                [1 ]Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, and The Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, United Kingdom
                Author notes
                This work was funded by the United Kingdom Medical Research Council (Grant Reference: SUAG/043 G101400), the Wellcome Trust [104908/Z/14/Z, 107496/Z/15/Z], and the National Institute for Health Research (NIHR) under the Research for Patient Benefit (RfPB) Programme (Grant Reference PB-PG-0214-33072), and supported by the NIHR Cambridge Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the United Kingdom Department of Health and Social Care. We are very grateful to Ed Watkins, David Barlow, Jill Newby, Peter Norton, Warren Mansell, Roz Shafran, Sarah Morris, Caitlin Hitchcock, Camilla Nord, Thomas Ehring and the research group at Ludwig Maximilian University Munich, and all of the attendees of the First International Conference on Transdiagnostic Approaches to Mental Health Challenges, held in Cambridge, United Kingdom, September 2018, for helpful discussion and comments. Tim Dalgleish and Melissa Black are joint first authors.
                [*] [* ]Correspondence concerning this article should be addressed to Melissa Black, Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, 15 Chaucer Road, Cambridge CB2 7EF, United Kingdom melissa.black@ 123456mrc-cbu.cam.ac.uk
                Author information
                http://orcid.org/0000-0003-1450-1140
                http://orcid.org/0000-0001-6237-5527
                http://orcid.org/0000-0003-4256-2530
                Article
                ccp_88_3_179 2020-10232-001
                10.1037/ccp0000482
                7027356
                32068421
                3338bb09-e38b-4aa5-9b69-e1d6617d2a0b
                © 2020 The Author(s)

                This article has been published under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Copyright for this article is retained by the author(s). Author(s) grant(s) the American Psychological Association the exclusive right to publish the article and identify itself as the original publisher.

                History
                : 21 November 2019
                : 25 November 2019
                Categories
                Article

                Clinical Psychology & Psychiatry
                transdiagnostic,mental health,classification,biopsychosocial processes,clinical interventions

                Comments

                Comment on this article